Go Ad-Free
My Alerts
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
MARKETS

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01031 | SECTOR: Pharmaceuticals & Drugs

| BSE 1215.70 7.25 (0.60%) | |

BSE Live

Jan 30, 16:01
1215.70 7.25 (0.60%)
Volume
AVERAGE VOLUME
5-Day
362,381
10-Day
313,456
30-Day
134,545
21,416

  • Prev. Close

    1208.45

  • Open Price

    1198.60

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jan 30, 15:59
1218.10 9.20 (0.76%)
Volume
AVERAGE VOLUME
5-Day
3,175,903
10-Day
2,729,566
30-Day
1,598,327
1,672,460

  • Prev. Close

    1208.90

  • Open Price

    1200.00

  • Bid Price (Qty.)

    1218.10 (63)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Cash Flow of Dr Reddys Laboratories (in Rs. Cr.) Mar 05  
  12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 13.85  
Net CashFlow From Operating Activities 229.91  
Net Cash Used In Investing Activities 93.85  
Net Cash Used From Financing Activities 157.85  
Foreign Exchange Gains / Losses 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00  
Net Inc/Dec In Cash And Cash Equivalents 481.62  
Cash And Cash Equivalents Begin of Year 453.88  
Cash And Cash Equivalents End Of Year 935.50  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347